OBJECTIVE: To investigate the hypothesis that alcohol consumption increases the risk of breast cancer mortality. METHODS: We examined breast cancer mortality in relation to self-reported alcohol consumption in women from the American Cancer Society Cancer Prevention Study (CPS)-II. After 14 years of follow-up, 1,442 eligible breast cancer deaths were observed among 242,010 women. Cox proportional hazards models were constructed for total alcohol consumption and for beer, wine, and liquor separately. RESULTS: Total alcohol consumption was associated with increased risk of fatal breast cancer among post- but not pre- or perimenopausal women. Even less than one drink/day was associated with up to a 30% increase in breast cancer mortality among postmenopausal women compared to non-drinkers (RR = 1.3, 95% CI: 1.1-1.6 for women drinking 0.26-<1 drink/day). When examined separately, consumption of beer, wine, and liquor each increased the risk of breast cancer among postmenopausal women. We found no evidence that alcohol consumption was more deleterious among women at high risk for breast cancer compared to average-risk women. CONCLUSION: This study adds to the evidence that postmenopausal women can reduce their risk of breast cancer by avoiding or minimizing their use of alcohol.
OBJECTIVE: To investigate the hypothesis that alcohol consumption increases the risk of breast cancer mortality. METHODS: We examined breast cancer mortality in relation to self-reported alcohol consumption in women from the American Cancer Society Cancer Prevention Study (CPS)-II. After 14 years of follow-up, 1,442 eligible breast cancer deaths were observed among 242,010 women. Cox proportional hazards models were constructed for total alcohol consumption and for beer, wine, and liquor separately. RESULTS: Total alcohol consumption was associated with increased risk of fatal breast cancer among post- but not pre- or perimenopausal women. Even less than one drink/day was associated with up to a 30% increase in breast cancer mortality among postmenopausal women compared to non-drinkers (RR = 1.3, 95% CI: 1.1-1.6 for women drinking 0.26-<1 drink/day). When examined separately, consumption of beer, wine, and liquor each increased the risk of breast cancer among postmenopausal women. We found no evidence that alcohol consumption was more deleterious among women at high risk for breast cancer compared to average-risk women. CONCLUSION: This study adds to the evidence that postmenopausal women can reduce their risk of breast cancer by avoiding or minimizing their use of alcohol.
Authors: Adaline E Heitz; Richard N Baumgartner; Kathy B Baumgartner; Stephanie D Boone Journal: Breast Cancer Res Treat Date: 2017-08-31 Impact factor: 4.872
Authors: Mónica E López; Celia P Kaplan; Anna M Nápoles; Jennifer C Livaudais; E Shelley Hwang; Susan L Stewart; Joan Bloom; Leah Karliner Journal: J Cancer Surviv Date: 2013-02-14 Impact factor: 4.442
Authors: Nadine Andrieu; David E Goldgar; Hongyan Li; Mary Beth Terry; Antonis C Antoniou; Kelly-Anne Phillips; Karin Kast; Thea M Mooij; Christoph Engel; Catherine Noguès; Dominique Stoppa-Lyonnet; Christine Lasset; Pascaline Berthet; Veronique Mari; Olivier Caron; Daniel Barrowdale; Debra Frost; Carole Brewer; D Gareth Evans; Louise Izatt; Lucy Side; Lisa Walker; Marc Tischkowitz; Mark T Rogers; Mary E Porteous; Katie Snape; Hanne E J Meijers-Heijboer; Johan J P Gille; Marinus J Blok; Nicoline Hoogerbrugge; Mary B Daly; Irene L Andrulis; Saundra S Buys; Esther M John; Sue-Anne McLachlan; Michael Friedlander; Yen Y Tan; Ana Osorio; Trinidad Caldes; Anna Jakubowska; Jacques Simard; Christian F Singer; Edith Olah; Marie Navratilova; Lenka Foretova; Anne-Marie Gerdes; Marie-José Roos-Blom; Brita Arver; Håkan Olsson; Rita K Schmutzler; John L Hopper; Roger L Milne; Douglas F Easton; Flora E Van Leeuwen; Matti A Rookus Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-12-02 Impact factor: 4.254
Authors: Lauren D Arnold; Alpa V Patel; Yan Yan; Eric J Jacobs; Michael J Thun; Eugenia E Calle; Graham A Colditz Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-09-01 Impact factor: 4.254
Authors: N Hamajima; K Hirose; K Tajima; T Rohan; E E Calle; C W Heath; R J Coates; J M Liff; R Talamini; N Chantarakul; S Koetsawang; D Rachawat; A Morabia; L Schuman; W Stewart; M Szklo; C Bain; F Schofield; V Siskind; P Band; A J Coldman; R P Gallagher; T G Hislop; P Yang; L M Kolonel; A M Y Nomura; J Hu; K C Johnson; Y Mao; S De Sanjosé; N Lee; P Marchbanks; H W Ory; H B Peterson; H G Wilson; P A Wingo; K Ebeling; D Kunde; P Nishan; J L Hopper; G Colditz; V Gajalanski; N Martin; T Pardthaisong; S Silpisornkosol; C Theetranont; B Boosiri; S Chutivongse; P Jimakorn; P Virutamasen; C Wongsrichanalai; M Ewertz; H O Adami; L Bergkvist; C Magnusson; I Persson; J Chang-Claude; C Paul; D C G Skegg; G F S Spears; P Boyle; T Evstifeeva; J R Daling; W B Hutchinson; K Malone; E A Noonan; J L Stanford; D B Thomas; N S Weiss; E White; N Andrieu; A Brêmond; F Clavel; B Gairard; J Lansac; L Piana; R Renaud; A Izquierdo; P Viladiu; H R Cuevas; P Ontiveros; A Palet; S B Salazar; N Aristizabel; A Cuadros; L Tryggvadottir; H Tulinius; A Bachelot; M G Lê; J Peto; S Franceschi; F Lubin; B Modan; E Ron; Y Wax; G D Friedman; R A Hiatt; F Levi; T Bishop; K Kosmelj; M Primic-Zakelj; B Ravnihar; J Stare; W L Beeson; G Fraser; R D Bullbrook; J Cuzick; S W Duffy; I S Fentiman; J L Hayward; D Y Wang; A J McMichael; K McPherson; R L Hanson; M C Leske; M C Mahoney; P C Nasca; A O Varma; A L Weinstein; T R Moller; H Olsson; J Ranstam; R A Goldbohm; P A van den Brandt; R A Apelo; J Baens; J R de la Cruz; B Javier; L B Lacaya; C A Ngelangel; C La Vecchia; E Negri; E Marubini; M Ferraroni; M Gerber; S Richardson; C Segala; D Gatei; P Kenya; A Kungu; J G Mati; L A Brinton; R Hoover; C Schairer; R Spirtas; H P Lee; M A Rookus; F E van Leeuwen; J A Schoenberg; M McCredie; M D Gammon; E A Clarke; L Jones; A Neil; M Vessey; D Yeates; P Appleby; E Banks; V Beral; D Bull; B Crossley; A Goodill; J Green; C Hermon; T Key; N Langston; C Lewis; G Reeves; R Collins; R Doll; R Peto; K Mabuchi; D Preston; P Hannaford; C Kay; L Rosero-Bixby; Y T Gao; F Jin; J-M Yuan; H Y Wei; T Yun; C Zhiheng; G Berry; J Cooper Booth; T Jelihovsky; R MacLennan; R Shearman; Q-S Wang; C-J Baines; A B Miller; C Wall; E Lund; H Stalsberg; X O Shu; W Zheng; K Katsouyanni; A Trichopoulou; D Trichopoulos; A Dabancens; L Martinez; R Molina; O Salas; F E Alexander; K Anderson; A R Folsom; B S Hulka; L Bernstein; S Enger; R W Haile; A Paganini-Hill; M C Pike; R K Ross; G Ursin; M C Yu; M P Longnecker; P Newcomb; L Bergkvist; A Kalache; T M M Farley; S Holck; O Meirik Journal: Br J Cancer Date: 2002-11-18 Impact factor: 7.640
Authors: Nur Zeinomar; Ashley Thai; Ann J Cloud; Jasmine A McDonald; Yuyan Liao; Mary Beth Terry Journal: PLoS One Date: 2017-12-15 Impact factor: 3.240